FAM228A

 

Full name: family with sequence similarity 228 member A Alias Symbol: FLJ30851
Type: protein-coding gene Cytoband: 2p23.3
Entrez ID: 653140 HGNC ID: HGNC:34418 Ensembl Gene: ENSG00000186453 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of FAM228A:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 FAM228A 653140 231386_at -0.2102 0.8102
GSE26886 FAM228A 653140 231386_at -0.0059 0.9816
GSE45670 FAM228A 653140 231386_at -0.2957 0.0032
GSE53622 FAM228A 653140 53869 0.0787 0.6508
GSE53624 FAM228A 653140 53869 0.1077 0.4341
GSE63941 FAM228A 653140 231386_at -0.5661 0.0234
GSE77861 FAM228A 653140 231386_at -0.1153 0.1494

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by FAM228A expression:

 

GSE53622GSE53624

 

Note: Click image to view full size file.  


Copy number change of FAM228A:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 FAM228A 653140 10 2 18
GSE20123 FAM228A 653140 10 2 18
GSE43470 FAM228A 653140 2 1 40
GSE46452 FAM228A 653140 3 4 52
GSE47630 FAM228A 653140 8 0 32
GSE54993 FAM228A 653140 0 7 63
GSE54994 FAM228A 653140 10 0 43
GSE60625 FAM228A 653140 0 3 8
GSE74703 FAM228A 653140 2 0 34
GSE74704 FAM228A 653140 9 1 10
TCGA FAM228A 653140 36 3 57

Total number of gains: 90; Total number of losses: 23; Total Number of normals: 375.  


 

Somatic mutations of FAM228A:

 

Generating mutation plots.

 

Highly correlated genes for FAM228A:

 

Showing top 20/21 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
FAM228AGPAT20.714543303
FAM228AMTFR1L0.64159303
FAM228APDK40.636035404
FAM228AMBD3L10.6152303
FAM228ASMPX0.601754303
FAM228AFOXP30.588214303
FAM228ADMGDH0.586624303
FAM228ABST10.584861403
FAM228ASCN7A0.580472403
FAM228AMYOC0.57605303
FAM228AIGF10.572198403
FAM228ASPATA60.569022303
FAM228AIP6K10.568841303
FAM228AC16orf890.563867303
FAM228AATP1A20.551217303
FAM228ARSPH10.544104303
FAM228AZNF4710.533128403
FAM228APTGIS0.530489403
FAM228APPOX0.529389403
FAM228APRUNE20.522777303

For details and further investigation, click here